Valiant Co

Valiant Co Rule of 40

The Rule of 40 of Valiant Co (002643.SZ) as of Oct 26, 2026 is 14.82 %. In the previous year, Rule of 40 was -2.95 % — a change of -603.14% (higher).

Rule of 40

14.82 %

YoY

-603.14%

Last updated:

Rule of 40 of Valiant Co is 2025 14.82 % . Rule of 40 of Valiant Co was 2024 -2.95 % . It decreases by -603.14% higher compared to the previous year.

The Valiant Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
26.21 CNY
Jan 1, 2019
30.38 CNY
Jan 1, 2020
23.38 CNY
Jan 1, 2021
67.00 CNY
Jan 1, 2022
35.72 CNY
Jan 1, 2023
7.00 CNY
Jan 1, 2024
-2.95 CNY
Jan 1, 2025
14.82 CNY
The Valiant Co Rule of 40 history
YEARRule of 40YoY
14.82 %-603.14%
-2.95 %-142.12%
7.00 %-80.42%
35.72 %-46.69%
67.00 %+186.63%
23.38 %-23.06%
30.38 %+15.91%
26.21 %-48.54%
50.93 %+50.80%
33.78 %-52.17%
70.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Rule of 40 of Valiant Co is 14.82 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Valiant Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Valiant Co

All Key Metrics — Valiant Co